View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AA44 Publication ID: Spring 1998 
Title: Implementation of the MCA; Regulation of Pseudoephedrine, Phenylpropanolamine, and Combination Ephedrine Drug Products and Reports of Certain Transactions to Nonregulated Persons 
Abstract: DEA is proposing amending its regulations to implement the requirements of the Comprehensive Methamphetamine Control Act of 1996 (MCA) establishing pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products as List I chemicals, and the MCA requirement that reports be submitted for certain distributions to nonregulated persons involving pseudoephedrine, phenylpropanolamine, and ephedrine, including drug products containing those chemicals. The MCA establishes pseudoephedrine, phenylpropanolamine, and combination ephedrine products as regulated List I chemicals, and requires that reports of certain distributions to nonregulated persons be reported each month. ^PTo minimize the impact of the new law, DEA is proposing to exempt retail distributors from the registration requirement. This exemption will provide the estimated 750,000 retail distributors with relief from the chemical control requirements of the regulations, including registration. Additionally, the existing exemptions from registration for CSA registrants and for distributors of prescription drug products will help minimize the impact of the requirements on other handlers of the products. 
Agency: Department of Justice(DOJ)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1300    21 CFR 1309    21 CFR 1310   
Legal Authority: 21 USC 802    21 USC 821 TO 824    21 USC 830    21 USC 871(b)    21 USC 875    21 USC 877    21 USC 951    21 USC 958   
Timetable:
Action Date FR Cite
NPRM  10/07/1997  62 FR 52294   
NPRM Comment Period End  12/08/1997  62 FR 52294   
Final Action  04/00/1998    
Additional Information: DEA number 163P
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Included in the Regulatory Plan: No 
Agency Contact:
G. Thomas Gitchel
Chief, Liaison and Policy Section, Office of Diversion Control
Department of Justice
Drug Enforcement Administration
Washington, DC 20537
Phone:202 307-7297